Furthermore, the presence of BRAF mutations in nevi[13-15] suggests that activation of the RAS/RAF/MEK/ERK pathway may participate to initiation of melanocytic transformation as well as that BRAF activation is necessary for inducing cell proliferation but not sufficient for the development of melanoma (additional molecular events are thus required to achieve full malignancy). The gene discussed is MAP2K7; the disease is melanoma.